Donohoue PA - Search Results

1

Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein.

Donohoue PA, van Dop C, McLean RH, White PC, Jospe N, Migeon CJ. Donohoue PA, et al. J Clin Endocrinol Metab. 1986 May;62(5):995-1002. doi: 10.1210/jcem-62-5-995. J Clin Endocrinol Metab. 1986. PMID: 3007562

2

Coupling of HLA-A3,Cw6,Bw47,DR7 and a normal CA21HB steroid 21-hydroxylase gene in the Old Order Amish.

Donohoue PA, Van Dop C, Migeon CJ, McLean RH, Bias WB. Donohoue PA, et al. J Clin Endocrinol Metab. 1987 Nov;65(5):980-6. doi: 10.1210/jcem-65-5-980. J Clin Endocrinol Metab. 1987. PMID: 2822757

3

Congenital adrenal hyperplasia: molecular mechanisms resulting in 21-hydroxylase deficiency.

Donohoue PA, Van Dop C, Jospe N, Migeon CJ. Donohoue PA, et al. Acta Endocrinol Suppl (Copenh). 1986;279:315-20. doi: 10.1530/acta.0.112s315. Acta Endocrinol Suppl (Copenh). 1986. PMID: 3022524 Review.

4

Prevalence of polymorphic 21-hydroxylase gene (CA21HB) mutations in salt-losing congenital adrenal hyperplasia.

Jospe N, Donohoue PA, Van Dop C, McLean RH, Bias WB, Migeon CJ. Jospe N, et al. Among authors: donohoue pa. Biochem Biophys Res Commun. 1987 Feb 13;142(3):798-804. doi: 10.1016/0006-291x(87)91484-7. Biochem Biophys Res Commun. 1987. PMID: 3030300 Free article.

5

Congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. Its molecular basis and its remaining therapeutic problems.

Migeon CJ, Donohoue PA. Migeon CJ, et al. Among authors: donohoue pa. Endocrinol Metab Clin North Am. 1991 Jun;20(2):277-96. Endocrinol Metab Clin North Am. 1991. PMID: 1879400 Review.

6

Exon 7 Ncol restriction site within CYP21B (steroid 21-hydroxylase) is a normal polymorphism.

Donohoue PA, Sandrini Neto R, Collins MM, Migeon CJ. Donohoue PA, et al. Mol Endocrinol. 1990 Sep;4(9):1354-62. doi: 10.1210/mend-4-9-1354. Mol Endocrinol. 1990. PMID: 1978247

7

Two distinct areas of unequal crossingover within the steroid 21-hydroxylase genes produce absence of CYP21B.

Donohoue PA, Jospe N, Migeon CJ, Van Dop C. Donohoue PA, et al. Genomics. 1989 Oct;5(3):397-406. doi: 10.1016/0888-7543(89)90002-5. Genomics. 1989. PMID: 2613228

8

Serum 3 alpha-androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy.

Reiner BJ, Donohoue PA, Migeon CJ, Berkovitz GD. Reiner BJ, et al. Among authors: donohoue pa. J Clin Endocrinol Metab. 1989 Jul;69(1):105-9. doi: 10.1210/jcem-69-1-105. J Clin Endocrinol Metab. 1989. PMID: 2732292

9

Restriction fragment analysis of duplication of the fourth component of complement (C4A).

McLean RH, Donohoue PA, Jospe N, Bias WB, Van Dop C, Migeon CJ. McLean RH, et al. Among authors: donohoue pa. Genomics. 1988 Jan;2(1):76-85. doi: 10.1016/0888-7543(88)90111-5. Genomics. 1988. PMID: 2838414

10

Restriction maps and restriction fragment length polymorphisms of the human 21-hydroxylase genes.

Donohoue PA, Jospe N, Migeon CJ, McLean RH, Bias WB, White PC, Van Dop C. Donohoue PA, et al. Biochem Biophys Res Commun. 1986 Apr 29;136(2):722-9. doi: 10.1016/0006-291x(86)90499-7. Biochem Biophys Res Commun. 1986. PMID: 3010994 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters